Moderna: The Software of Life

Business Breakdowns | 16 June 2021 | 1h 09m | Listen Later | iTunes
Interview breaking down Moderna and its innovative RNA platform that was one of the first to develop a covid-19 vaccine. Starts with a primer on the biotech industry, genetic modification, and how Moderna’s platform represents a breakthrough in the industry. Then discusses what differentiates Moderna’s business model, how Moderna’s science could lead to faster and higher efficacy drug development, with key takeaways for investors and operators.

Leave a Reply

Your email address will not be published.